Veeda Clinical Research

Jump to

Veeda Clinical Research: CX Partners-led consortium looks to sell majority stake, eyes $600 mn -$650 mn valuation

In December 2018, a consortium of growth-oriented private equity firms led by CX Partners acquired a 'significant' equity ownership in Veeda.
CX Partners-backed Veeda Clinical Research appoints Mahesh Bhalgat as Group CEO

In November 2018, a consortium of private equity investors led by CX Partners acquired a significant equity ownership in Veeda Clinical Research.
Global Health, Veeda Clinical receive Sebi approval to launch IPOs

Veeda Clinical Research's Rs 831-crore IPO consists of an issuance of fresh equity shares worth up to Rs 331.60 crore and an OFS of Rs 500 crore by promoters and existing shareholders.
Veeda Clinical Research files draft papers with Sebi to raise Rs 831 crore via IPO

The initial share-sale will consist of an issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders, according to the draft red herring prospectus (DRHP).

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Veeda Clinical Research

Veeda Clinical Research: CX Partners-led consortium looks to sell majority stake, eyes $600 mn -$650 mn valuation

CX Partners-backed Veeda Clinical Research appoints Mahesh Bhalgat as Group CEO

Global Health, Veeda Clinical receive Sebi approval to launch IPOs

Veeda Clinical Research files draft papers with Sebi to raise Rs 831 crore via IPO